ABSTRACT
La encefalitis frente al receptor de N-metil-D-aspartato (NMDAR) está incluida en el grupo de las encefalitis autoinmunes. Es más frecuente en mujeres en edad reproductiva. Las manifestaciones clínicas iniciales pueden ser similares a los pródromos de las infecciones virales. En ocasiones se asocia con la presencia de neoplasias. El diagnóstico oportuno y la instauración precoz del tratamiento inmunomodulador es determinante en el pronóstico. En el presente artículo, se realiza una revisión de la literatura y se presentan dos casos de encefaltis anti-NMDAR en diferentes edades de la vida.
Encephalitis against N-methyl-D-aspartate receptor (NMDAR) is included in the group of autoimmune encephalitis. It is more common in women in reproductive age. The first clinical features may be similar to viral infections prodromes. It is sometimes related to neoplasms. The accurate diagnosis and early administration of immunomodulatory therapy is critical to the prognosis. In this article, a review of the literature was performed and two cases of anti-NMDAR encephalitis in different stages of life are presented.
ABSTRACT
Messenger RNAs containing premature termination codons (PTCs) are selectively eliminated by nonsense-mediated mRNA decay (NMD). Paradoxically, although cytoplasmic ribosomes are the only known species capable of PTC recognition, in mammals many PTC-containing mRNAs are apparently eliminated prior to release from the nucleus. To determine whether PTCs can influence events within the nucleus proper, we studied the immunoglobulin (Ig)-mu and T cell receptor (TCR)-beta genes using fluorescent in situ hybridization (FISH). Alleles containing PTCs, but not those containing a missense mutation or a frameshift followed by frame-correcting mutations, exhibited elevated levels of pre-mRNA, which accumulated at or near the site of transcription. Our data indicate that mRNA reading frame can influence events at or near the site of gene transcription.
Subject(s)
Codon, Nonsense/metabolism , Genes, Immunoglobulin , Genes, T-Cell Receptor/genetics , Immunoglobulin mu-Chains/genetics , RNA Precursors/metabolism , Transcription, Genetic , Animals , B-Lymphocytes , Blotting, Northern , Codon, Nonsense/genetics , HeLa Cells , Humans , Immunoglobulin mu-Chains/metabolism , In Situ Hybridization, Fluorescence , Mice , Molecular Sequence Data , RNA Precursors/genetics , RNA Splicing , Transfection , Tumor Cells, CulturedABSTRACT
Proteins are responsible for most cellular and extra-cellular functions. If altered, proteins can loose their normal activity and/or gain new properties. Either way the consequences may be deleterious for the cell and lead to disease at the organism level. Not surprisingly, eukaryotes have evolved mechanisms to recognize abnormal messenger RNAs and prevent them from producing faulty proteins. Protein-encoding genes are transcribed in the nucleus by RNA polymerase II as precursor RNAs that undergo extensive processing before being translocated to the cytoplasm for translation by the ribosomes. This spatial and temporal separation between RNA and protein synthesis offers an immense opportunity for control and regulation. Here we review recent studies that are beginning to unravel how the coupling between transcription, processing and transport of mRNAs contributes to control the quality of gene expression in the nucleus.
Subject(s)
Cell Nucleus/metabolism , Gene Expression Regulation/physiology , RNA Processing, Post-Transcriptional/physiology , RNA, Messenger/metabolism , Humans , Models, Biological , Myotonic Dystrophy/metabolism , Quality Control , RNA Splicing , Transcription, Genetic , beta-Thalassemia/metabolismABSTRACT
Twenty-six patients with single enhancing brain lesion (SEL) were openly assigned to receive single-day praziquantel therapy (n=14), or not (n=12). From 14 treated patients, complete resolution was found in 11, partial resolution in two, and the remaining case was later diagnosed as an arteriovenous malformation. Side effects presented in only one patient and remitted in the same day with symptomatic treatment. Conversely, the lesions persisted unchanged in six of 12 patients in the non-treatment group. Untreated patients with persisting lesions were prescribed praziquantel treatment. After this, SELs disappeared in three cases, other diagnoses (brain tuberculoma and arteriovenous malformation) were made in two, and one was not evaluated. When analyzed in regard to the baseline serology, resolution of lesions on computed tomography was found in 13 (complete=12, partial=1) of 14 seropositive patients, whereas it only happened in six (complete=5, partial=1) of 12 seronegative patients. Serological screening defines a subset of SEL patients with good prognosis. If antiparasitic therapy is to be used in patients with SEL, and we cannot find a strong argument against it, single-day praziquantel is the regimen of choice based on duration, costs, and minimal side effects.
Subject(s)
Anthelmintics/therapeutic use , Neurocysticercosis/drug therapy , Praziquantel/therapeutic use , Adolescent , Adult , Animals , Female , Humans , Male , Middle Aged , Neurocysticercosis/pathology , Taenia/pathogenicity , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
We describe here for the first time the site of retention within the nucleus of pre-mRNA processing mutants unable to be exported to the cytoplasm. Fluorescence in situ hybridization was used to detect transcripts from human beta-globin genes that are either normal or defective in splicing or 3' end formation. Nuclear transcripts of both wild-type and mutant RNAs are detected only as intranuclear foci that colocalize with the template gene locus. The kinetics of transcript release from the site of transcription was assessed by treatment of cells with the transcriptional inhibitors actinomycin D, alpha-amanitin and DRB. These drugs induce the rapid disappearance of nuclear foci corresponding to wild-type human beta-globin RNA. In contrast, pre-mRNA mutants defective in either splicing or 3' end formation and which fail to be transported to the cytoplasm, are retained at the site of transcription. Therefore, 3' end processing and splicing appear to be rate limiting for release of mRNA from the site of transcription.
Subject(s)
Globins/genetics , RNA Precursors/metabolism , RNA Processing, Post-Transcriptional/genetics , Amanitins/pharmacology , Cell Line , Dactinomycin/pharmacology , Dichlororibofuranosylbenzimidazole/pharmacology , Humans , In Situ Hybridization, Fluorescence , Kinetics , Mutation , RNA Splicing , RNA, Messenger/metabolism , Spliceosomes/genetics , Transcription, GeneticABSTRACT
Within the nucleus, protein-encoding genes are transcribed into messenger RNA by RNA polymerase II. Messenger RNAs migrate to the cytoplasm, but before reaching their final destination the primary transcripts must undergo a series of modifications that include 5'-capping, splicing, and 3'-cleavage/polyadenylation. Errors in these processing events can originate aberrant products that, if translated, would produce abnormal proteins. Therefore, it is not surprising that eukaryotes have evolved a surveillance mechanism that recognizes and rapidly degrades aberrant mRNAs. Recent experiments provide exciting insights into how proper mRNAs are distinguished and selected for export. Transcription by RNA polymerase II is directly coupled to pre-mRNA processing, and the mechanism that targets the processing machinery to the polymerase complex suggests a model for co-transcriptional proofreading. Furthermore, there is evidence that at least some mRNAs move randomly throughout the nucleus, presumably by free diffusion. In this light, retention of aberrant mRNAs by the transcription/processing machinery is crucial to prevent their diffusion to the nuclear pores and eventual translocation to the cytoplasm.
Subject(s)
Cell Nucleus/metabolism , RNA, Messenger/metabolism , Animals , Biological Transport , Cell Nucleus/genetics , Humans , RNA, Messenger/genetics , Transcription, GeneticABSTRACT
At present several lines of evidence indicate that the nucleus is functionally compartmentalized into discrete structures with defined properties. For instance, it is well established that the molecular machines involved in replication, transcription, and RNA processing assemble into morphological entities but it remains unclear whether these correspond to autonomous "organelles" or rather represent temporary accumulations of either active factors recruited onto DNA templates or inactive factors stored in the vicinity of genes. According to the latter view, the spatial distribution of genes during interphase should play a major role in the subnuclear organization of nonchromatin components such as replication, transcription, and processing factors, and in this article we discuss current ideas on the functional compartmentalization of chromosomes and genes within the nucleus.
Subject(s)
Cell Nucleus/genetics , Cell Nucleus/ultrastructure , Chromosomes, Human/genetics , Chromosomes, Human/ultrastructure , Binding Sites , Cell Compartmentation , Cell Nucleolus/genetics , Cell Nucleolus/metabolism , Cell Nucleus/metabolism , HeLa Cells , Humans , RNA/biosynthesis , RNA/genetics , RNA, Ribosomal/genetics , Transcription Factors/metabolism , Uridine Triphosphate/analogs & derivatives , Uridine Triphosphate/metabolismABSTRACT
The nuclear distribution of GATA transcription factors in murine haemopoietic cells was examined by indirect immunofluorescence. Specific bright foci of GATA-1 fluorescence were observed in erythroleukaemia cells and primary murine erythroblasts and megakaryocytes, in addition to diffuse nucleoplasmic localization. These foci, which were preferentially found adjacent to nucleoli or at the nuclear periphery, did not represent sites of active transcription or binding of GATA-1 to consensus sites in the beta-globin loci. Immunoelectron microscopy demonstrated the presence of intensely labelled structures likely to represent the GATA-1 foci seen by immunofluorescence. The GATA-1 nuclear bodies differed from previously described nuclear structures and there was no co-localization with nuclear antigens involved in RNA processing or other ubiquitous (Spl, c-Jun and TBP) or haemopoietic (NF-E2) transcription factors. Interestingly, GATA-2 and GATA-3 proteins also localized to the same nuclear bodies in cell lines co-expressing GATA-1 and -2 or GATA-1 and -3 gene products. This pattern of distribution is, thus far, unique to the GATA transcription factors and suggests a protein-protein interaction with other components of the nuclear bodies via the GATA zinc finger domain.